Lea Leiv
- SEC CIK
- 0000939012
No open-market purchases or sales filed in the past year.
Current role at each company
- CRVS Corvus Pharmaceuticals, Inc.Chief Financial Officeras of Dec 8, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lea Leiv as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2022 (view filing) | Dec 13-14 | 2 days | Lea LeivChief Financial Officer | PPurchase | +34.0K | $0.7518 | +$25.6K | +34.3%133.2K after | 2 lots |
| Mar 17, 2022 (view filing) | Mar 16-17 | 1 day | Lea LeivChief Financial Officer | PPurchase | +49.0K | $1.57 | +$77.0K | +97.7%99.2K after | 2 lots |